- Home
- MRSN vs CGO Comparison
MRSN vs CGO Comparison
Compare MRSN & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRSN | CGO |
|---|---|---|
| Founded | 2001 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.8M | 114.5M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRSN | CGO |
|---|---|---|
| Price | $27.78 | $11.43 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $30.38 | N/A |
| AVG Volume (30 Days) | ★ 237.3K | 34.7K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.25% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $33,180,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.21 | $7.90 |
| 52 Week High | $70.73 | $10.93 |
Technical Indicators
Market Signals| Indicator | MRSN | CGO |
|---|---|---|
| Relative Strength Index (RSI) | 83.68 | 49.32 |
| Support Level | $27.31 | $11.21 |
| Resistance Level | $28.36 | $11.38 |
| Average True Range (ATR) | 0.52 | 0.17 |
| MACD | -0.26 | 0.05 |
| Stochastic Oscillator | 51.65 | 88.89 |
Price Performance
Historical ComparisonAbout MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.